News

PDS Biotech's Strategic Role at Upcoming Oncology Conference

PDS Biotech's Strategic Role at Upcoming Oncology Conference

PDS Biotech's Engagement in Oncology Innovations

PDS Biotechnology Corporation (NASDAQ: PDSB), an organization at the forefront of immunotherapy, is taking significant strides in addressing cancer treatment. With a mission to revolutionize how the immune system identifies and eliminates cancer cells, PDS Biotech is set to participate in a notable industry event aimed at advancing oncology practices.

Upcoming Conference Participation

The B. Riley Securities Precision Oncology & Radiopharma Conference 2025 is the stage where PDS Biotech will highlight its pivotal developments. Dr. Frank Bedu-Addo, the President and CEO of the company, will be engaging in a fireside chat at this prestigious gathering. This event will occur shortly after the official announcement, marking a key moment for PDS Biotech.

Conference Details

Attendees of this event can expect an impactful session scheduled for:

B. Riley Securities Precision Oncology & Radiopharma Conference 2025
Date: February 28, 2025
Session Type: Fireside Chat
Track: Holmes II – Precision Oncology Track
Time: 11:30 AM - 12:00 PM ET

Focus on Pivotal Clinical Trials

PDS Biotech is advancing in its clinical research, particularly concentrating on HPV16-positive head and neck squamous cell cancers. The company is gearing up to initiate a pivotal clinical trial that will be a vital step in the development of its lead program. This shows their commitment to leveraging innovative research to enhance cancer treatment methodologies.

Investigational Therapies

One of the key players in PDS Biotech’s arsenal is its targeted immunotherapy, Versamune. This investigational therapy is being developed alongside existing treatments like immune checkpoint inhibitors. Such combinations are designed to enhance the effectiveness of cancer therapies, creating a comprehensive approach to patient care.

Leadership Engagement

During the conference, PDS leadership plans to conduct one-on-one meetings with investors and partners, showcasing their commitment to transparency and collaboration in the biotech field.Engagements like these emphasize the company's proactive approach towards fostering partnerships that can aid in advancing their research and commercialization efforts.

Future Directions and Initiatives

PDS Biotech is dedicated to not only advancing their clinical trials but also ensuring that their developments align with patient needs and industry standards. Their combination therapies, including PDS01ADC, which is an IL-12 fused antibody drug conjugate, demonstrate their innovative strategies. By integrating multiple treatment approaches, PDS Biotech aims to maximize therapeutic outcomes for patients battling cancer.

Company Contact Information

For anyone interested in learning more about PDS Biotech's initiatives, they can reach out directly:

Investor Contact:
Mike Moyer
LifeSci Advisors
Phone: +1 (617) 308-4306
Email: mmoyer@lifesciadvisors.com

Media Contact:
Janine McCargo
6 Degrees
Email: jmccargo@6degreespr.com

Frequently Asked Questions

What is the main focus of PDS Biotech?

PDS Biotech focuses on developing advanced immunotherapy treatments for various types of cancers.

Who is presenting at the B. Riley Securities Conference?

Dr. Frank Bedu-Addo, the CEO, will be presenting at the conference.

What is Versamune?

Versamune is an investigational immunotherapy being developed by PDS Biotech to enhance the immune system's response to cancers.

Where will the conference take place?

The conference will be held at the Lotte New York Palace Hotel in New York City.

How can one access information post-conference?

An archived transcript of the fireside chat will be available on the PDS Biotech website after the event.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 231

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 445

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 155

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 212

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Growth Stocks to Consider: Nvidia, Super Micro, Royal Caribbean

Updated Category News Views 255

Exploring High-Performing Stocks After the Pandemic Following the pandemic, the stock market has experienced a remarkable recovery, largely driven by advancements in artificial intelligence and a resurgence in travel demand. Among the standout performers in this landscape, three companies have particularly excelled, showcasing impressive growth potential. Let’s delve...

Continue Reading
Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 58

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
Nebius Group: A Thriving Alternative in AI Computing Sector

Updated Category News Views 453

Nebius Group N.V. Takes on Major Hyperscalers Analyst Alexander Platt from D.A. Davidson & Co. recently launched coverage on Nebius Group N.V. (NASDAQ: NBIS) with a Buy rating, showcasing a promising future as an alternative to leading hyperscalers in the AI computing space. Transforming AI Computing with Transparent Solutions The ever-evolving demand for AI solutions has...

Continue Reading
Innovative Waste Tracking Enhances Hospital Sustainability Efforts

Updated Category News Views 123

Enhancing Hospital Sustainability Through Waste Management In today's driven healthcare landscape, managing waste effectively is more important than ever. remedi, a notable player in the regulated medical waste processing sector, has recently announced an expansion of its waste tracking and reporting capabilities. This initiative aims to assist hospitals in gaining...

Continue Reading
Insights on Core Molding Technologies Stock Movements

Updated Category News Views 148

Core Molding Technologies Stock Activity Overview Recently, there’s been significant trading activity surrounding Core Molding Technologies Inc (NYSEMKT:CMT). Renee R. Anderson, the Executive Vice President of Human Resources, sold shares valued at $32,094. This sale involved 1,783 shares, each priced at $18.00, which caught the attention of both investors and market...

Continue Reading